Real-time enrollment status for this b-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 3:27 AM UTC
| NCT Number | NCT04546399 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 461 participants |
| Active Locations | 209 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | June 12, 2026 (Jun 12, 2026) |
As of August 31, 2026: Clinical trial NCT04546399 is currently recruiting participants. This phase2 study for b-cell acute lymphoblastic leukemia is actively seeking new participants at 209 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04546399 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 209 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04546399 was last updated Jun 12, 2026 (June 12, 2026). HelloStudys verifies this status automatically.